05/27/2026
Clinical supply chains often struggle to keep up with the actual pace of a study.
When the logistics are too rigid, you end up with a massive gap between what’s produced and what patients actually receive.
It’s a primary reason why about half of all IMP kits end up as waste.
The problem is that standard metrics like "on-time delivery" don't tell the whole story.
A kit can show up on schedule and still be unusable if there was a deviation during transit. To fix this, the focus has to shift toward more proactive management.
Using predictive modeling to manage inventory levels allows for more flexibility. Instead of over-stocking every site, you can maintain buffer stocks at central hubs and move them based on where patient recruitment is actually happening.
This level of detail is even more important for biologics. Keeping these products within a strict temperature range requires more than just a good box.
It takes specialized infrastructure and sensors that give you enough lead time to step in before a shipment is ruined.
The goal is to make the supply chain a non-issue. When the logistics are handled with enough precision, the focus stays on the science and the patients.
Read more: https://hanzologistics.com/the-future-of-life-science-supply-chain-management/
📦